Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue 1.4 Market Analysis by Type 1.4.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Cell Therapy 1.4.3 Tissue Engineering 1.5 Market by Application 1.5.1 Global Cell Therapy and Tissue Engineering Market Share by Application: 2020 VS 2026 1.5.2 Cell Defects 1.5.3 Genetic Diseases 1.5.4 Neurodegenerative Diseases 1.5.5 Tissue Malignancies 1.5.6 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Cell Therapy and Tissue Engineering Market Perspective (2015-2026) 2.2 Cell Therapy and Tissue Engineering Growth Trends by Regions 2.2.1 Cell Therapy and Tissue Engineering Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Cell Therapy and Tissue Engineering Historic Market Share by Regions (2015-2020) 2.2.3 Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Cell Therapy and Tissue Engineering Market Growth Strategy 2.3.6 Primary Interviews with Key Cell Therapy and Tissue Engineering Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Cell Therapy and Tissue Engineering Players by Market Size 3.1.1 Global Top Cell Therapy and Tissue Engineering Players by Revenue (2015-2020) 3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Players (2015-2020) 3.1.3 Global Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Cell Therapy and Tissue Engineering Market Concentration Ratio 3.2.1 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Cell Therapy and Tissue Engineering Revenue in 2019 3.3 Cell Therapy and Tissue Engineering Key Players Head office and Area Served 3.4 Key Players Cell Therapy and Tissue Engineering Product Solution and Service 3.5 Date of Enter into Cell Therapy and Tissue Engineering Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Type (2015-2020) 4.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2021-2026) 5 Cell Therapy and Tissue Engineering Breakdown Data by Application (2015-2026) 5.1 Global Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) 5.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Cell Therapy and Tissue Engineering Market Size (2015-2020) 6.2 Cell Therapy and Tissue Engineering Key Players in North America (2019-2020) 6.3 North America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) 6.4 North America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) 7 Europe 7.1 Europe Cell Therapy and Tissue Engineering Market Size (2015-2020) 7.2 Cell Therapy and Tissue Engineering Key Players in Europe (2019-2020) 7.3 Europe Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) 7.4 Europe Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) 8 China 8.1 China Cell Therapy and Tissue Engineering Market Size (2015-2020) 8.2 Cell Therapy and Tissue Engineering Key Players in China (2019-2020) 8.3 China Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) 8.4 China Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) 9 Japan 9.1 Japan Cell Therapy and Tissue Engineering Market Size (2015-2020) 9.2 Cell Therapy and Tissue Engineering Key Players in Japan (2019-2020) 9.3 Japan Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) 9.4 Japan Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Cell Therapy and Tissue Engineering Market Size (2015-2020) 10.2 Cell Therapy and Tissue Engineering Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) 10.4 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) 11 India 11.1 India Cell Therapy and Tissue Engineering Market Size (2015-2020) 11.2 Cell Therapy and Tissue Engineering Key Players in India (2019-2020) 11.3 India Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) 11.4 India Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Cell Therapy and Tissue Engineering Market Size (2015-2020) 12.2 Cell Therapy and Tissue Engineering Key Players in Central & South America (2019-2020) 12.3 Central & South America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) 12.4 Central & South America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Betalin Therapeutics 13.1.1 Betalin Therapeutics Company Details 13.1.2 Betalin Therapeutics Business Overview and Its Total Revenue 13.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Introduction 13.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)) 13.1.5 Betalin Therapeutics Recent Development 13.2 BioCardia, Inc 13.2.1 BioCardia, Inc Company Details 13.2.2 BioCardia, Inc Business Overview and Its Total Revenue 13.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Introduction 13.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 13.2.5 BioCardia, Inc Recent Development 13.3 BioReliance Corporation 13.3.1 BioReliance Corporation Company Details 13.3.2 BioReliance Corporation Business Overview and Its Total Revenue 13.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Introduction 13.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 13.3.5 BioReliance Corporation Recent Development 13.4 Biosolution Co. 13.4.1 Biosolution Co. Company Details 13.4.2 Biosolution Co. Business Overview and Its Total Revenue 13.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Introduction 13.4.4 Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 13.4.5 Biosolution Co. Recent Development 13.5 Brainstorm Cell Therapeutics, Inc 13.5.1 Brainstorm Cell Therapeutics, Inc Company Details 13.5.2 Brainstorm Cell Therapeutics, Inc Business Overview and Its Total Revenue 13.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction 13.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 13.5.5 Brainstorm Cell Therapeutics, Inc Recent Development 13.6 MaxCyte, Inc 13.6.1 MaxCyte, Inc Company Details 13.6.2 MaxCyte, Inc Business Overview and Its Total Revenue 13.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Introduction 13.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 13.6.5 MaxCyte, Inc Recent Development 13.7 Medigene AG 13.7.1 Medigene AG Company Details 13.7.2 Medigene AG Business Overview and Its Total Revenue 13.7.3 Medigene AG Cell Therapy and Tissue Engineering Introduction 13.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 13.7.5 Medigene AG Recent Development 13.8 MEDIPOST CO. 13.8.1 MEDIPOST CO. Company Details 13.8.2 MEDIPOST CO. Business Overview and Its Total Revenue 13.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Introduction 13.8.4 MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 13.8.5 MEDIPOST CO. Recent Development 13.9 Mesoblast Limited 13.9.1 Mesoblast Limited Company Details 13.9.2 Mesoblast Limited Business Overview and Its Total Revenue 13.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Introduction 13.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 13.9.5 Mesoblast Limited Recent Development 13.10 Miromatrix Medical, Inc. 13.10.1 Miromatrix Medical, Inc. Company Details 13.10.2 Miromatrix Medical, Inc. Business Overview and Its Total Revenue 13.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Introduction 13.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 13.10.5 Miromatrix Medical, Inc. Recent Development 13.11 MolMed S.p.A 10.11.1 MolMed S.p.A Company Details 10.11.2 MolMed S.p.A Business Overview and Its Total Revenue 10.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Introduction 10.11.4 MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.11.5 MolMed S.p.A Recent Development 13.12 Mustang Bio, Inc 10.12.1 Mustang Bio, Inc Company Details 10.12.2 Mustang Bio, Inc Business Overview and Its Total Revenue 10.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Introduction 10.12.4 Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.12.5 Mustang Bio, Inc Recent Development 13.13 NantKwest, Inc. 10.13.1 NantKwest, Inc. Company Details 10.13.2 NantKwest, Inc. Business Overview and Its Total Revenue 10.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Introduction 10.13.4 NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.13.5 NantKwest, Inc. Recent Development 13.14 Neuralstem, Inc 10.14.1 Neuralstem, Inc Company Details 10.14.2 Neuralstem, Inc Business Overview and Its Total Revenue 10.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Introduction 10.14.4 Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.14.5 Neuralstem, Inc Recent Development 13.15 NexImmune, Inc. 10.15.1 NexImmune, Inc. Company Details 10.15.2 NexImmune, Inc. Business Overview and Its Total Revenue 10.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Introduction 10.15.4 NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.15.5 NexImmune, Inc. Recent Development 13.16 Nohla Therapeutics, Inc 10.16.1 Nohla Therapeutics, Inc Company Details 10.16.2 Nohla Therapeutics, Inc Business Overview and Its Total Revenue 10.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction 10.16.4 Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.16.5 Nohla Therapeutics, Inc Recent Development 13.17 ReNeuron Group plc 10.17.1 ReNeuron Group plc Company Details 10.17.2 ReNeuron Group plc Business Overview and Its Total Revenue 10.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction 10.17.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.17.5 ReNeuron Group plc Recent Development 13.18 Richter-Helm BioLogics GmbH & Co. KG 10.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Details 10.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview and Its Total Revenue 10.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction 10.18.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.18.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development 13.19 RoosterBio, Inc 10.19.1 RoosterBio, Inc Company Details 10.19.2 RoosterBio, Inc Business Overview and Its Total Revenue 10.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction 10.19.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.19.5 RoosterBio, Inc Recent Development 13.20 RoslinCT 10.20.1 RoslinCT Company Details 10.20.2 RoslinCT Business Overview and Its Total Revenue 10.20.3 RoslinCT Cell Therapy and Tissue Engineering Introduction 10.20.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.20.5 RoslinCT Recent Development 13.21 Rubius Therapeutics, Inc. 10.21.1 Rubius Therapeutics, Inc. Company Details 10.21.2 Rubius Therapeutics, Inc. Business Overview and Its Total Revenue 10.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction 10.21.4 Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.21.5 Rubius Therapeutics, Inc. Recent Development 13.22 Sangamo Therapeutics, Inc 10.22.1 Sangamo Therapeutics, Inc Company Details 10.22.2 Sangamo Therapeutics, Inc Business Overview and Its Total Revenue 10.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction 10.22.4 Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.22.5 Sangamo Therapeutics, Inc Recent Development 13.23 Voyager Therapeutics, Inc 10.23.1 Voyager Therapeutics, Inc Company Details 10.23.2 Voyager Therapeutics, Inc Business Overview and Its Total Revenue 10.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction 10.23.4 Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.23.5 Voyager Therapeutics, Inc Recent Development 13.24 Waisman Biomanufacturing 10.24.1 Waisman Biomanufacturing Company Details 10.24.2 Waisman Biomanufacturing Business Overview and Its Total Revenue 10.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Introduction 10.24.4 Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.24.5 Waisman Biomanufacturing Recent Development 13.25 WindMIL Therapeutics, Inc. 10.25.1 WindMIL Therapeutics, Inc. Company Details 10.25.2 WindMIL Therapeutics, Inc. Business Overview and Its Total Revenue 10.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction 10.25.4 WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.25.5 WindMIL Therapeutics, Inc. Recent Development 13.26 Wuxi App Tec, Inc. 10.26.1 Wuxi App Tec, Inc. Company Details 10.26.2 Wuxi App Tec, Inc. Business Overview and Its Total Revenue 10.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Introduction 10.26.4 Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.26.5 Wuxi App Tec, Inc. Recent Development 13.27 ReNeuron Group plc 10.27.1 ReNeuron Group plc Company Details 10.27.2 ReNeuron Group plc Business Overview and Its Total Revenue 10.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction 10.27.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.27.5 ReNeuron Group plc Recent Development 13.28 Richter-Helm BioLogics GmbH & Co. KG 10.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Details 10.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview and Its Total Revenue 10.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction 10.28.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.28.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development 13.29 RoosterBio, Inc 10.29.1 RoosterBio, Inc Company Details 10.29.2 RoosterBio, Inc Business Overview and Its Total Revenue 10.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction 10.29.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.29.5 RoosterBio, Inc Recent Development 13.30 RoslinCT 10.30.1 RoslinCT Company Details 10.30.2 RoslinCT Business Overview and Its Total Revenue 10.30.3 RoslinCT Cell Therapy and Tissue Engineering Introduction 10.30.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) 10.30.5 RoslinCT Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Cell Therapy and Tissue Engineering Key Market Segments Table 2. Key Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue Table 3. Ranking of Global Top Cell Therapy and Tissue Engineering Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Cell Therapy Table 6. Key Players of Tissue Engineering Table 7. Global Cell Therapy and Tissue Engineering Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Cell Therapy and Tissue Engineering Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Cell Therapy and Tissue Engineering Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Cell Therapy and Tissue Engineering Market Share by Regions (2015-2020) Table 11. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Cell Therapy and Tissue Engineering Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Cell Therapy and Tissue Engineering Market Growth Strategy Table 17. Main Points Interviewed from Key Cell Therapy and Tissue Engineering Players Table 18. Global Cell Therapy and Tissue Engineering Revenue by Players (2015-2020) (Million US$) Table 19. Global Cell Therapy and Tissue Engineering Market Share by Players (2015-2020) Table 20. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2019) Table 21. Global Cell Therapy and Tissue Engineering by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Cell Therapy and Tissue Engineering Product Solution and Service Table 24. Date of Enter into Cell Therapy and Tissue Engineering Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$) Table 27. Global Cell Therapy and Tissue Engineering Market Size Share by Type (2015-2020) Table 28. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2021-2026) Table 29. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2015-2020) Table 30. Global Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$) Table 31. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2021-2026) Table 32. North America Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$) Table 33. North America Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020) Table 34. North America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$) Table 35. North America Cell Therapy and Tissue Engineering Market Share by Type (2015-2020) Table 36. North America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$) Table 37. North America Cell Therapy and Tissue Engineering Market Share by Application (2015-2020) Table 38. Europe Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020) Table 40. Europe Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$) Table 41. Europe Cell Therapy and Tissue Engineering Market Share by Type (2015-2020) Table 42. Europe Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$) Table 43. Europe Cell Therapy and Tissue Engineering Market Share by Application (2015-2020) Table 44. China Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$) Table 45. China Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020) Table 46. China Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$) Table 47. China Cell Therapy and Tissue Engineering Market Share by Type (2015-2020) Table 48. China Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$) Table 49. China Cell Therapy and Tissue Engineering Market Share by Application (2015-2020) Table 50. Japan Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020) Table 52. Japan Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$) Table 53. Japan Cell Therapy and Tissue Engineering Market Share by Type (2015-2020) Table 54. Japan Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$) Table 55. Japan Cell Therapy and Tissue Engineering Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020) Table 58. Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Cell Therapy and Tissue Engineering Market Share by Type (2015-2020) Table 60. Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Cell Therapy and Tissue Engineering Market Share by Application (2015-2020) Table 62. India Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$) Table 63. India Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020) Table 64. India Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$) Table 65. India Cell Therapy and Tissue Engineering Market Share by Type (2015-2020) Table 66. India Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$) Table 67. India Cell Therapy and Tissue Engineering Market Share by Application (2015-2020) Table 68. Central & South America Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020) Table 70. Central & South America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Cell Therapy and Tissue Engineering Market Share by Type (2015-2020) Table 72. Central & South America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Cell Therapy and Tissue Engineering Market Share by Application (2015-2020) Table 74. Betalin Therapeutics Company Details Table 75. Betalin Therapeutics Business Overview Table 76. Betalin Therapeutics Product Table 77. Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 78. Betalin Therapeutics Recent Development Table 79. BioCardia, Inc Company Details Table 80. BioCardia, Inc Business Overview Table 81. BioCardia, Inc Product Table 82. BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 83. BioCardia, Inc Recent Development Table 84. BioReliance Corporation Company Details Table 85. BioReliance Corporation Business Overview Table 86. BioReliance Corporation Product Table 87. BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 88. BioReliance Corporation Recent Development Table 89. Biosolution Co. Company Details Table 90. Biosolution Co. Business Overview Table 91. Biosolution Co. Product Table 92. Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 93. Biosolution Co. Recent Development Table 94. Brainstorm Cell Therapeutics, Inc Company Details Table 95. Brainstorm Cell Therapeutics, Inc Business Overview Table 96. Brainstorm Cell Therapeutics, Inc Product Table 97. Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 98. Brainstorm Cell Therapeutics, Inc Recent Development Table 99. MaxCyte, Inc Company Details Table 100. MaxCyte, Inc Business Overview Table 101. MaxCyte, Inc Product Table 102. MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 103. MaxCyte, Inc Recent Development Table 104. Medigene AG Company Details Table 105. Medigene AG Business Overview Table 106. Medigene AG Product Table 107. Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 108. Medigene AG Recent Development Table 109. MEDIPOST CO. Business Overview Table 110. MEDIPOST CO. Product Table 111. MEDIPOST CO. Company Details Table 112. MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 113. MEDIPOST CO. Recent Development Table 114. Mesoblast Limited Company Details Table 115. Mesoblast Limited Business Overview Table 116. Mesoblast Limited Product Table 117. Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 118. Mesoblast Limited Recent Development Table 119. Miromatrix Medical, Inc. Company Details Table 120. Miromatrix Medical, Inc. Business Overview Table 121. Miromatrix Medical, Inc. Product Table 122. Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 123. Miromatrix Medical, Inc. Recent Development Table 124. MolMed S.p.A Company Details Table 125. MolMed S.p.A Business Overview Table 126. MolMed S.p.A Product Table 127. MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 128. MolMed S.p.A Recent Development Table 129. Mustang Bio, Inc Company Details Table 130. Mustang Bio, Inc Business Overview Table 131. Mustang Bio, Inc Product Table 132. Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 133. Mustang Bio, Inc Recent Development Table 134. NantKwest, Inc. Company Details Table 135. NantKwest, Inc. Business Overview Table 136. NantKwest, Inc. Product Table 137. NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 138. NantKwest, Inc. Recent Development Table 139. Neuralstem, Inc Company Details Table 140. Neuralstem, Inc Business Overview Table 141. Neuralstem, Inc Product Table 142. Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 143. Neuralstem, Inc Recent Development Table 144. NexImmune, Inc. Company Details Table 145. NexImmune, Inc. Business Overview Table 146. NexImmune, Inc. Product Table 147. NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 148. NexImmune, Inc. Recent Development Table 149. Nohla Therapeutics, Inc Company Details Table 150. Nohla Therapeutics, Inc Business Overview Table 151. Nohla Therapeutics, Inc Product Table 152. Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 153. Nohla Therapeutics, Inc Recent Development Table 154. ReNeuron Group plc Company Details Table 155. ReNeuron Group plc Business Overview Table 156. ReNeuron Group plc Product Table 157. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 158. ReNeuron Group plc Recent Development Table 159. Richter-Helm BioLogics GmbH & Co. KG Company Details Table 160. Richter-Helm BioLogics GmbH & Co. KG Business Overview Table 161. Richter-Helm BioLogics GmbH & Co. KG Product Table 162. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 163. Richter-Helm BioLogics GmbH & Co. KG Recent Development Table 164. RoosterBio, Inc Company Details Table 165. RoosterBio, Inc Business Overview Table 166. RoosterBio, Inc Product Table 167. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 168. RoosterBio, Inc Recent Development Table 169. RoslinCT Company Details Table 170. RoslinCT Business Overview Table 171. RoslinCT Product Table 172. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 173. RoslinCT Recent Development Table 174. Rubius Therapeutics, Inc. Company Details Table 175. Rubius Therapeutics, Inc. Business Overview Table 176. Rubius Therapeutics, Inc. Product Table 177. Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 178. Rubius Therapeutics, Inc. Recent Development Table 179. Sangamo Therapeutics, Inc Company Details Table 180. Sangamo Therapeutics, Inc Business Overview Table 181. Sangamo Therapeutics, Inc Product Table 182. Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 183. Sangamo Therapeutics, Inc Recent Development Table 184. Voyager Therapeutics, Inc Company Details Table 185. Voyager Therapeutics, Inc Business Overview Table 186. Voyager Therapeutics, Inc Product Table 187. Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 188. Voyager Therapeutics, Inc Recent Development Table 189. Waisman Biomanufacturing Company Details Table 190. Waisman Biomanufacturing Business Overview Table 191. Waisman Biomanufacturing Product Table 192. Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 193. Waisman Biomanufacturing Recent Development Table 194. WindMIL Therapeutics, Inc. Company Details Table 195. WindMIL Therapeutics, Inc. Business Overview Table 196. WindMIL Therapeutics, Inc. Product Table 197. WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 198. WindMIL Therapeutics, Inc. Recent Development Table 199. Wuxi App Tec, Inc. Company Details Table 200. Wuxi App Tec, Inc. Business Overview Table 201. Wuxi App Tec, Inc. Product Table 202. Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 203. Wuxi App Tec, Inc. Recent Development Table 204. ReNeuron Group plc Company Details Table 205. ReNeuron Group plc Business Overview Table 206. ReNeuron Group plc Product Table 207. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 208. ReNeuron Group plc Recent Development Table 209. Richter-Helm BioLogics GmbH & Co. KG Company Details Table 210. Richter-Helm BioLogics GmbH & Co. KG Business Overview Table 211. Richter-Helm BioLogics GmbH & Co. KG Product Table 212. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 213. Richter-Helm BioLogics GmbH & Co. KG Recent Development Table 214. RoosterBio, Inc Company Details Table 215. RoosterBio, Inc Business Overview Table 216. RoosterBio, Inc Product Table 217. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 218. RoosterBio, Inc Recent Development Table 219. RoslinCT Company Details Table 220. RoslinCT Business Overview Table 221. RoslinCT Product Table 222. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$) Table 223. RoslinCT Recent Development Table 224. Research Programs/Design for This Report Table 225. Key Data Information from Secondary Sources Table 226. Key Data Information from Primary Sources List of Figures Figure 1. Global Cell Therapy and Tissue Engineering Market Share by Type: 2020 VS 2026 Figure 2. Cell Therapy Features Figure 3. Tissue Engineering Features Figure 4. Global Cell Therapy and Tissue Engineering Market Share by Application: 2020 VS 2026 Figure 5. Cell Defects Case Studies Figure 6. Genetic Diseases Case Studies Figure 7. Neurodegenerative Diseases Case Studies Figure 8. Tissue Malignancies Case Studies Figure 9. Others Case Studies Figure 10. Cell Therapy and Tissue Engineering Report Years Considered Figure 11. Global Cell Therapy and Tissue Engineering Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Cell Therapy and Tissue Engineering Market Share by Regions: 2020 VS 2026 Figure 13. Global Cell Therapy and Tissue Engineering Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Cell Therapy and Tissue Engineering Market Share by Players in 2019 Figure 16. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2019 Figure 18. North America Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Betalin Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Betalin Therapeutics Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 27. BioCardia, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. BioCardia, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 29. BioReliance Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. BioReliance Corporation Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 31. Biosolution Co. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Biosolution Co. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 33. Brainstorm Cell Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Brainstorm Cell Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 35. MaxCyte, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. MaxCyte, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 37. Medigene AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Medigene AG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 39. MEDIPOST CO. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. MEDIPOST CO. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 41. Mesoblast Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Mesoblast Limited Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 43. Miromatrix Medical, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Miromatrix Medical, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 45. MolMed S.p.A Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. MolMed S.p.A Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 47. Mustang Bio, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Mustang Bio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 49. NantKwest, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. NantKwest, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 51. Neuralstem, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Neuralstem, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 53. NexImmune, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. NexImmune, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 55. Nohla Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 56. Nohla Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 57. ReNeuron Group plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 58. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 59. Richter-Helm BioLogics GmbH & Co. KG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 60. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 61. RoosterBio, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 62. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 63. RoslinCT Total Revenue (US$ Million): 2019 Compared with 2018 Figure 64. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Betalin Therapeutics BioCardia, Inc BioReliance Corporation Biosolution Co. Brainstorm Cell Therapeutics, Inc MaxCyte, Inc Medigene AG MEDIPOST CO. Mesoblast Limited Miromatrix Medical, Inc. MolMed S.p.A Mustang Bio, Inc NantKwest, Inc. Neuralstem, Inc NexImmune, Inc. Nohla Therapeutics, Inc ReNeuron Group plc Richter-Helm BioLogics GmbH & Co. KG RoosterBio, Inc RoslinCT Rubius Therapeutics, Inc. Sangamo Therapeutics, Inc Voyager Therapeutics, Inc Waisman Biomanufacturing WindMIL Therapeutics, Inc. Wuxi App Tec, Inc. ReNeuron Group plc Richter-Helm BioLogics GmbH & Co. KG RoosterBio, Inc RoslinCT